Filing Flows › Vivos Therapeutics (VVOS) › Service revenue
Vivos Therapeutics (VVOS) Service revenue by quarter
Vivos Therapeutics' Service revenue was $3.8M in Q2 2026 (second quarter 2026), +3% from Q1 2026. Over the last 7 quarters it ranged from $1.2M (Q1 2025) to $4.6M (Q3 2025).
| Quarter | Service revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $3.8M | +3% | +97% |
| Q1 2026 | $3.7M | +15% | +208% |
| Q4 2025 | $3.2M | -30% | +125% |
| Q3 2025 | $4.6M | +138% | — |
| Q2 2025 | $1.9M | +60% | — |
| Q1 2025 | $1.2M | -16% | — |
| Q4 2024 | $1.4M | — | — |
Q2 2026 at a glance
Vivos Therapeutics, Q2 2026: revenue $5.2M (+35% year over year), operating margin -93.6%, net loss $5.5M, operating cash flow −$3.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Vivos Therapeutics' Service revenue?
Vivos Therapeutics' Service revenue was $3.8M in Q2 2026 (second quarter 2026), +3% from Q1 2026.
How has Vivos Therapeutics' Service revenue changed?
Over the last 7 quarters it ranged from $1.2M (Q1 2025) to $4.6M (Q3 2025).